Prostate-specific antigen kallikrein and acute myocardial infarction: Where we are. Where are we going?

International Journal of Cardiology

Volumn 146, Issue 1, 2011, Pages

  Patanè, Salvatore ^a   Marte, Filippo ^a  

^a Cardiologia Nuovo Presidio Ospedaliero Cutroni Zodda Barcellona PdG(Me)   (Italy)

Author keywords

Acute myocardial infarction (AMI); Kallikrein kinin system; Prostate specific antigen (PSA)

Indexed keywords

KALLIKREIN; KALLIKREIN 2; KININ; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ARTICLE; HUMAN; KALLIKREIN KININ SYSTEM; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; HUMANS; MALE; MYOCARDIAL INFARCTION; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TISSUE KALLIKREINS;

EID: 78650852379     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.12.174     Document Type: Article

References (32)

1. K.W.K. Watt, P.J. Lee, T. M'Timkulu, W.P. Chan, and R. Loor Human prostate specific antigen: structural and functional similarity with serine proteases Proc Natl Acad Sci U S A 83 1986 3166 3170
2. A. Lundwall, and H. Lilja Molecular cloning of human prostatespecific antigen cDNA FEBS Lett 214 1987 317 322
3. M. Crook, K. Preston, and I. Lancaster Serum prostatic specific-antigen concentrations in acute myocardial infarction Clin Chem 43 9 1997 Sep 1670
4. P.H.J. Riegman, R.J. Vlietstra, and P. Klaasen The prostate specific antigen gene and the human glandular kallikrein-1 gene are tandemly located on chromosome 19 FEBS Lett 247 1 1989 123 126
5. P. Murtha, D.J. Tindall, and C.Y.F. Young Androgen induction of a human prostate-specific kallikrein, hKLK2: characterization of an androgen response element in the 5′ promoter region of the gene Biochemistry 32 1993 6459 6464
6. J.E. Oesterling Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate J Urol 145 1991 907 923
7. R.B. Shifman, F.R. Ahmann, and A. Elvick Analytical and physiological characteristics of prostate-specific antigen and prostatic acid phosphatase in serum compared Clin Chem 33 1987 2086 2088
8. P.G. Hagood, R.O. Parra, and J.A. Rauscher Nontraumatic evaluation of prostate specific antigen following cardiac surgery and extracorporeal cardiopulmonary bypass J Urol 152 1994 2043 2045
9. P.R. Kiran Markedly raised serum prostate specific antigen levels. Prostatic infarction rather than malignancy? Aust Fam Physician 30 5 2001 May 458 460 [Review]
10. J. Koller-Strametz, M. Fritzer, and M. Gwechenberger Elevation of prostate-specific markers after cardiopulmonary resuscitation Circulation 102 3 2000 Jul 18 290 293
11. J.J. Pollen, and A. Dreilinger Immunohistochemical identification of prostatic acid phosphatase and prostate specific antigen in female periurethral glands Urology 23 1984 303 304
12. S.L. Tepper, J. Jagirdar, D. Heath, and S.A. Geller Homology between the female paraurethral (Skene's) glands and the prostate Arch Pathol Lab Med 108 1984 423 425
13. H.C. Graves Nonprostatic sources of prostate-specific antigen: a steroid hormone dependent phenomenon? Clin Chem 41 1 1995 Jan 7 9
14. H. Yu, and E.P. Diamandis Prostate-specific antigen in milk of lactating women Clin Chem 41 1995 54 58
15. H. Yu, E.P. Diamandis, and D.J.A. Sutherland Immunoreactive prostate specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age Clin Biochem 27 1994 75 79
16. S. Patanè, and F. Marte Paroxysmal ventricular tachycardia and paroxysmal atrial fibrillation associated with subclinical hyperthyroidism, chronic renal failure and elevation of prostate-specific antigen during acute myocardial infarction Int J Cardiol 138 2010 e44 e46
17. S. Patanè, F. Marte, G. Di Bella, and G. Ciccarello Changing axis deviation and elevation of prostate-specific antigen during acute myocardial infarction Int J Cardiol 135 2009 e44 e46
18. S. Patanè, F. Marte, G. Di Bella, and G. Ciccarello Changing axis deviation, paroxysmal atrial fibrillation and elevation of prostate-specific antigen during acute myocardial infarction Int J Cardiol 137 2009 e44 e46
19. S. Patanè, and F. Marte Paroxysmal atrial fibrillation during acute myocardial infarction associated with subclinical hyperthyroidism, severe three vessels coronary artery disease and elevation of prostate-specific antigen after TURP Int J Cardiol 138 2010 e44 e46
20. S. Patanè, F. Marte, M. Sturiale, R. Grassi, and F. Patanè Significant coronary artery disease associated with coronary artery aneurysm and elevation of prostate-specific antigen during acute myocardial infarction Int J Cardiol 141 2010 e44 e46
21. M. Koreny, J. Koller-Strametz, and A. Geppert Elevation of prostatic markers following cardiogenic shock Intensive Care Med 27 2 2001 Feb 447
22. R. Berent, J. Auer, and M. Porodko Influence of cardiopulmonary resuscitation on levels of tumour markers Eur J Cancer Care (Engl) 15 3 2006 Jul 252 256
23. S. Patanè, and F. Marte Prostate-specific antigen and acute myocardial infarction: a possible new intriguing scenario Int J Cardiol 134 2009 e44 e46
24. J.N. Sharma The kallikrein-kinin system: from mediator of inflammation to modulator of cardioprotection Inflammopharmacology 12 5-6 2005 591 596 [Review]
25. J.N. Sharma Role of tissue kallikrein-kininogen-kinin pathways in the cardiovascular system Arch Med Res 37 3 2006 Apr 299 306 [Review]
26. M.C. Charlesworth, C.Y. Young, V.M. Miller, and D.J. Tindall Kininogenase activity of prostate-derived human glandular kallikrein (hK2) purified from seminal fluid J Androl 20 2 1999 Mar-Apr 220 229
27. H.G. Rittenhouse, J.A. Finlay, S.D. Mikolajczyk, and A.W. Partin Human kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate Crit Rev Clin Lab Sci 35 4 1998 275 368
28. S.R. Denmeade, J. Lövgren, S.R. Khan, H. Lilja, and J.T. Isaacs Activation of latent protease function of pro-hK2, but not pro-PSA, involves autoprocessing Prostate 48 2 2001 Jul 1 122 126
29. L. Bourgeois, M. Brillard-Bourdet, and D. Deperthes Serpin-derived peptide substrates for investigating the substrate specificity of human tissue kallikreins hK1 and hK2 J Biol Chem 272 47 1997 Nov 21 29590 29595
30. G. Frenette, R.R. Tremblay, C. Lazure, and J.Y. Dube Prostatic kallikrein (hk2), but not prostate-specific antigen (hk3), activates single-chain urokinase-type plasminogen activator Int J Cancer 71 1997 897 899
31. S.D. Mikolajczyk, L.S. Millar, A. Kumar, and M.S. Saedi Prostatic human kallikrein 2 inactivates and complexes with plasminogen activator inhibitor-1 Int J Cancer 81 3 1999 May 5 438 442
32. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150